Autologous stem cell transplant for multiple myeloma patients 70 years or olderEli Muchtar, Morie A. Gertz, Nelson Leung et al.|Bone Marrow Transplantation|2016Cited by 63
Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosisSurbhi Sidana, Morie A. Gertz, M Hasib Sidiqi et al.|American Journal of Hematology|2019Cited by 52
Impact of consolidation therapy post autologous stem cell transplant in patients with light chain amyloidosisAbdullah S. Al Saleh, Morie A. Gertz, M Hasib Sidiqi et al.|American Journal of Hematology|2019Cited by 23
Differences in engraftment with day-1 compared with day-2 melphalan prior to stem cell infusion in myeloma patients receiving autologous stem cell transplantAbdullah S. Al Saleh, Morie A. Gertz, M Hasib Sidiqi et al.|Bone Marrow Transplantation|2020Cited by 13
Safety and efficacy of propylene glycol-free melphalan as conditioning in patients with AL amyloidosis undergoing stem cell transplantationM Hasib Sidiqi, Morie A. Gertz, Mohammed A. Aljama et al.|Bone Marrow Transplantation|2018Cited by 9